NCT05266248View on ClinicalTrials.gov

Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed and Fasted States

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

February 3, 2022

Study Completion Date

February 3, 2022

Conditions

Pharmacokinetics

Interventions

OTHER

250 mg encapsulated caffeine

Zero calorie 500 ml (16.9 oz) flavored, carbonated energy beverage

Trial Locations (1)

33705

GCP Research, St. Petersburg

All Listed Sponsors

lead

PepsiCo Global R&D

INDUSTRY